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Purpose: The aim of the present study was to test a structural equation model of patient 
satisfaction with different key facets of methadone maintenance treatment (MMT). In this 
model, the three dimensions of patient satisfaction with methadone as a medication (ie, personal 
functioning and well-being, anti-addictive effect on heroin, and anti-addictive effect on non-
opioid substances) were expected to predict satisfaction with the basic interventions delivered 
by the staff of treatment centers to implement MMT.
Patients and methods: A sample of 210 heroin-dependent patients, resistant to MMT treat-
ment (mean age =41.66 years, SD =6.50; 75.7% male), participated voluntarily in this study. 
Preliminary analysis based on exploratory structural equation modeling supported the expected 
three-factor measurement model of the scale to assess satisfaction with medications for addiction 
treatment – methadone for heroin addiction. Moreover, the 15 items measuring staff’s basic 
interventions were shown to be compatible with the expected single-factor measurement model. 
Then, both measurement models were included in a structural model.
Results: Results of this model show that patient satisfaction with the compatibility of metha-
done with personal functioning and well-being, as well as with the anti-addictive effects of 
methadone on non-opioid substances, predicts satisfaction with basic interventions conducted 
at methadone treatment centers (β=0.191 and β=0.152, respectively).
Conclusion: Our results provide further understanding regarding patient satisfaction with 
MMT, which could help professionals to better understand patient perspective and experience 
during MMT.
Keywords: exploratory structural equation modeling, satisfaction with medication, satisfaction 
with treatment, treatment quality, methadone non-responders
Introduction
Methadone maintenance treatment (MMT) is considered the gold standard of treatment 
of heroin dependence as different studies show that it reduces heroin use, non-opioid 
substance use, crime, HIV infection, and mortality.1–3 Nevertheless, some patients do 
not achieve the MMT goal of stopping compulsive use of heroin,4,5 which hinders the 
management of complications associated with heroin dependence. According to the 
World Health Organization, MMT outcomes could be improved through the assess-
ment of patient satisfaction with this treatment.6
Patient satisfaction with treatment is a global measure of treatment quality reflect-
ing patients’ evaluation of the actual experience of care received compared to their 
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care expectations.7,8 The resulting subjective state includes 
a wide range of patient evaluations regarding the different 
therapeutic interventions received, such as skills and man-
ners of physicians, psychologists, nurses or social workers, 
and perceived safety and effectiveness of medications. 
Specifically, Trujols et al conceptualized patient satisfac-
tion in MMT as a global process involving four interrelated 
and overlapping dimensions:9 satisfaction with methadone 
as a medication (eg, effectiveness, impact on daily life/
functioning), satisfaction with treatment (eg, non-pharmaco-
logical interventions, professional skills), methadone holding 
dose, and dose adequacy.
Similarly, Shikiar and Rentz hypothesized that patient 
satisfaction with medication is related to satisfaction with 
other treatment interventions, such as physician–patient inter-
actions or those physician recommendations that go beyond 
the medication prescribed.8 This hypothesis requires attention 
in the field of MMT, for both clinical and research reasons. 
It makes sense to think that physicians are concerned about 
whether patient satisfaction with methadone as a medication 
could be linked to patient satisfaction with the interventions 
delivered to implement MMT (eg, help offered to improve 
patients’ social relationships and self-care). Pérez de los 
Cobos et al explored this proposition using a single question 
to assess patient opinion about methadone as a medication 
and found that this opinion independently predicted patient 
satisfaction with MMT.10 Furthermore, previous research 
argued that satisfaction with methadone as a medication 
would be mediating the relation between polymorphisms of 
a gene involved in the metabolism of methadone (ie, cyto-
chrome P-450 enzyme 2D6 [CYP2D6]) and satisfaction with 
basic interventions.11
Patient satisfaction in MMT has been primarily measured 
with generic instruments, such as the General Satisfaction 
Questionnaire12 or the Client Satisfaction Questionnaire.13 In 
addition, as patient satisfaction is a broad construct including 
different dimensions,9 it appears interesting to target each 
facet with instruments specifically designed to assess opioid 
maintenance treatments. For example, Pérez de los Cobos et 
al validated the Verona service satisfaction scale for metha-
done treatment (VSSS-MT) to measure patient satisfaction 
with the services received at methadone treatment centers.14 
Similarly, the scale to assess satisfaction with medications 
for addiction treatment – methadone for heroin addiction 
(SASMAT-METHER) – was developed to assess patient 
satisfaction with methadone as a medication.15
The SASMAT-METHER is a 17-item questionnaire 
targeting three dimensions of patient satisfaction with metha-
done as a medication: personal functioning and well-being, 
anti-addictive effect on heroin, and anti-addictive effect on 
non-opioid substances.16 Personal functioning and well-being 
assess patient satisfaction regarding methadone compatibility 
with other activities, its influence on overall physical health, 
its impact on enjoying pleasant things of life, and the toler-
ability of its adverse effects. The other two subscales evaluate 
patient satisfaction with methadone in reducing consumption, 
craving, withdrawal, thoughts about, and attention paid to 
1) heroin or 2) non-opioid substances. Previous research has 
not only offered evidence supporting the psychometric prop-
erties of this instrument but also advocated that further studies 
are needed to replicate its reliability and factor structure.15
The aim of the present study was to test the hypothesis 
of heroin-dependent patient satisfaction with methadone 
as a medication impacting their satisfaction with the basic 
interventions delivered by the staff to implement MMT. To 
do so, we tested a structural equation model (SEM) where the 
three dimensions of the SASMAT-METHER (ie, personal 
functioning and well-being, anti-addictive effect on heroin, 
and anti-addictive effect on non-opioid substances) were 
predictors of satisfaction with the basic interventions factor 
of the VSSS-MT (ie, satisfaction with skills and manners of 
physicians and nurses, help received to improve self-care 
and inter-personal relationships, and overall satisfaction with 
services delivered at MMT centers). The study sample com-
prised of non-responders to MMT (ie, patients who are unable 
to stop substance use)17 because, in this group of patients, the 
impact of satisfaction with methadone on satisfaction with 
basic interventions could hinder the implementation of any 
clinical interventions aimed at treating heroin dependence. As 
a secondary purpose, we provide further evidence regarding 
the measurement model of the SASMAT-METHER.
Patients and methods
Participants and procedure
The sample in this study included 210 patients who met 
DSM-IV criteria for heroin dependence18 and had received 
MMT for at least the previous 3 months. Exclusion criteria 
included mental disorders that could hinder patient assess-
ment (eg, neurocognitive disorders, substance intoxication) 
and difficulty answering the survey due to limited literacy 
or poor Spanish language proficiency. All patients were 
recruited at the Addictive Behaviors Unit of Sant Pau Hospital 
(Barcelona) by using accidental sampling. All participants 
had been referred from other methadone-treatment centers 
in Barcelona and were at the Addictive Behaviors Unit of 
Sant Pau Hospital for clinical assessment and/or short-term 
treatments at the time of the study. No compensation was 
offered to patients for his/her participation in this research. 




Patient satisfaction with methadone medication and treatment
The study protocol was approved by the institutional review 
board of Sant Pau Hospital. 
Two research assistants who were not part of the clinical 
staff recruited the participants and conducted their assess-
ment. Participants read the information of the investigation 
and signed an informed consent before beginning their 
data collection. Participation was voluntary and confi-
dentiality was guaranteed. Completion of the instruments 
lasted ~45 minutes. The survey began in February 2007 and 
ended in June 2015.
instruments
scale to assess satisfaction with medications for 
addiction treatment–methadone for heroin addiction
Participants responded to SASMAT-METHER in order to 
assess their satisfaction with methadone for heroin treatment.15 
All items were introduced with the stem: “What is your overall 
opinion about ….” SASMAT-METHER includes three factors 
(number of items presented in brackets): personal functioning 
and well-being (seven items), anti-addictive effect on heroin 
(five items), and anti-addictive effect on other substances 
(five items). Examples of items for each scale are as follows: 
“… the impact of taking methadone on your overall physical 
health?” “… the efficacy of methadone to stop thinking about 
heroin?”, and “… the efficacy of methadone in reducing crav-
ing for other substances of abuse?”, respectively. Response 
categories for SASMAT-METHER items are ordered using 
a 5-point Likert scale (1=terrible, 2=generally unsatisfac-
tory, 3=mixed, 4=generally satisfactory, and 5=excellent). 
Four items also include a “not applicable” response option: 
1) one evaluates satisfaction with the efficacy of methadone 
to interfere with the effects of heroin; 2) one assesses compat-
ibility between methadone and other medications; or 3) two 
assess compatibility of methadone with work/study activities. 
Similarly, the five items assessing the anti-addictive effect of 
methadone on secondary substances of abuse (eg, cocaine) 
may not be applicable if these secondary substances were not 
consumed at least 20 times during the treatment period. All 
response options of the SASMAT-METHER are presented 
with alternate directionality. SASMAT-METHER scores are 
obtained by taking an average of the applicable items and thus 
the scores for each scale can range from 1 to 5.
Basic interventions implemented by the staff 
of treatment centers
Patient satisfaction with the services delivered by metha-
done-treatment centers, which are essential for methadone 
administration, was measured with the basic interventions 
subscale of the VSSS-MT.14 This subscale is the first factor 
of the VSSS-MT and comprises 15 items. The basic interven-
tions dimension assesses the satisfaction with the activity of 
those professionals who are essential to deliver the pharma-
cotherapeutic component of MMT (ie, doctors and nurses), 
along with the help received in two areas that are particularly 
deteriorated in heroin-dependent patients: interpersonal 
relationships and self-care. However, basic interventions do 
not include other components of MMT, such as psychosocial 
treatment (eg, individual or family therapy) or the activity 
of other professionals (eg, psychologists or social workers). 
The basic interventions items were introduced by using the 
stem: “What is your overall feeling about the ...” and an 
example of an item is: “... ability of physicians (internists or 
psychiatrists) to listen to and understand your problems?” 
Participants responded to the items by using a 5-point Likert 
scale (1=terrible, 2=generally unsatisfactory, 3=mixed, 
4=generally satisfactory, 5=excellent). Response categories 
were presented with alternate directionality. The score of 
basic interventions is obtained by taking an average of item 
responses, and thus the scale score ranges from 1 to 5.
Data analysis
Data were analyzed using SPSS version 17 (SPSS Inc., 
Chicago, IL, USA) and Mplus software version 7.0.19 Pre-
liminary analyses included the study of missing values, 
distribution of our data, and scale reliability. Scale reli-
ability was assessed using McDonald’s coefficient omega 
(ω).20 Subsequently, we analyzed the factor structure of the 
questionnaires used in this study in order to provide evidence 
supporting their internal structure. The measurement model 
of SASMAT-METHER was tested comparing a series of 
nested measurement models: Model 1 was based on an 
exploratory structural equation modeling (ESEM) approach 
where items were allowed to load into three correlated factors 
including cross-loadings;21 Model 2 assumed a confirmatory 
factor analysis (CFA) structure where each item loaded into 
one of the three correlated factors and cross-loadings were 
fixed to zero; Model 3 was also based on a CFA approach and 
tested for a three uncorrelated factor structure (ie, correlations 
between factors were constrained to 0); and Model 4 assessed 
a single-factor structure. Comparison between Model 1 and 
Model 2 was a test of the tenability of all item cross-loadings 
being 0. Comparison between Model 2 and Model 3 assessed 
the presence of correlations between SASMAT-METHER 
factors. Finally, comparison between Model 2 and Model 4 
was a test of discriminant validity between factors. Regard-
ing the basic interventions measurement model, we tested 
a single-factor structure. Consequently, we assessed its 
discriminant validity by testing a global measurement model 





including the SASMAT-METHER measurement model as 
well as the basic interventions factor.
In this study, all measurement models and the structural 
model were estimated using the weighted least squares mean 
and variance adjusted (WLSMV) estimator, an estimator 
that is appropriate for Likert scales.19 Geomin rotation was 
used to define the correlated factors in the ESEM model. We 
employed different fit indices to test the fit of the measure-
ment models to the data: χ2 statistic, root mean square error 
of approximation (RMSEA)22 including its 90% CI, com-
parative fix index (CFI),23 and Tucker-Lewis index (TLI).24 
A non-significant χ2 value indicates a good fit between the 
observed and the implied covariance matrices. The threshold 
of acceptable fit for the RMSEA is #0.08 (for an excellent 
fit, #0.06).25 Moreover, for its CI, ,0.05 (lower bound) 
and ,0.08 (upper bound) are acceptable, and 0 (lower bound) 
and ,0.05 (upper bound) are good.26 In addition, CFI and TLI 
values .0.95 are considered as indicators of excellent fit.26 It 
should be noted that those interpretation criteria were initially 
proposed for CFA models with quantitative indicators, but 
they have been subsequently applied to ESEM models and 
categorical indicators.27
The comparison between SASMAT-METHER nested 
measurement models was based on χ2 along with CFI, TLI, 
and RMSEA differences. According to previous research, 
the more parsimonious model should be selected only 
when changes in CFI are ,0.01 and increases in RMSEA 
are ,0.015.28,29 Changes in the TLI were evaluated following 
the guidelines associated with CFI changes.30
Then, in order to provide evidence supporting the dis-
criminant validity of the latent factors that would be included 
within the structural model, we tested the correlations between 
these factors. Correlation coefficients were interpreted using 
Zhu’s criterion:31 0–0.19 =no correlation, 0.20–0.39 =low cor-
relation, 0.40–0.59 =moderate correlation, 0.60–0.79 =moder-
ately high correlation, and $0.80 =high correlation. As a final 
step of our data analyses, we constructed an SEM to evaluate 
the relationship between SASMAT-METHER factors and 
basic interventions. Specifically, it was hypothesized that all 
three SASMAT-METHER factors (ie, personal functioning 
and well-being, anti-addictive effect on heroin, and anti-
addictive effect on other substances) would positively predict 
patients’ perceptions of the basic interventions conducted at 
their methadone-treatment centers. The fit of the SEM to the 
data was assessed using the same criteria explained earlier, 
although these criteria should be treated with a degree of 
caution.32
Results
Preliminary analyses and scale reliability
Table 1 presents the description of participants. As can be 
observed, the sample was mostly male. Percentages of miss-
ing data were below 5% for most of the items (Table 2). 
According to Graham’s criterion,33 our patterns of missing 
data were assumed not to have consequences on subsequent 
data analyses. However, three items had a percentage of 
missing values .5% (item 7 of personal functioning and 
well-being, items 2 and 14 of basic interventions). In those 
cases, missing values corresponded to the option “not appli-
cable” in the questionnaire.14,15 In this study, we used pairwise 
deletion of missing data. In general, participants chose mid 
and mid to high values to evaluate their satisfaction with 
methadone and methadone-treatment centers. In addition, 
descriptive statistics for the scales tested in the study are 
presented in Table 4.
Table 1 Description of the participants
Variables Participants 
(n=210)
Age (years), mean (sD) 41.66 (6.50)
Male gender (%) 75.7
Years of education, mean (sD) 10.65 (2.87)
Marital status (%)
single 56.7
Married or living with a partner 19.5
separated or divorced 18.6
Widowed 5.2
heroin use
Age of onset (years), mean (sD) 20.53 (6.28)
Time of use (months), mean (sD) 137.22 (84.15)





Duration lifetime (months), mean (sD) 109.21 (71.50)
current dose (mg/d), mean (sD) 66.75 (82.53)










Note: History of use of non-opioid substances was defined as consumption of these 
substances at least 20 times in a lifetime (without a prescription in the case of 
benzodiazepines). 
Abbreviation: MMT, methadone maintenance treatment.













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Evidence supporting scale reliability was obtained by 
calculating McDonald’s coefficient omega (ω).17 Values for 
each scale were as follows: ω













In order to provide evidence supporting the internal struc-
ture of the SASMAT-METHER, we tested a hierarchy of 
nested measurement models (Table 3). The ESEM mea-
surement model (Model 1) showed an acceptable fit to 
the data (χ2 [df] =200.546 [88], p,0.001, RMSEA [90% 
CI] =0.078 [0.064–0.092], CFI =0.983, TLI =0.973) and 
significantly outperformed the other models. The ESEM 
model also exhibited salient factor loadings (.0.40)34 and 
non-remarkable cross-loadings, the highest being 0.276 
(Table 2). Although the three-factor CFA correlated model 
(Model 2) also exhibited a good fit to the data, the ESEM 
model was preferred and then selected to be used in all 
subsequent analyses (comparison between Models 1 and 
2: Δχ2 [Δdf] =115.675 [28], p,0.001, ΔRMSEA =0.012, 
ΔCFI =-0.013, ΔTLI =-0.009).
Then, we tested the global measurement model including 
all the indicators considered in this study. SASMAT-METHER 
was defined using the ESEM three-factor structure and the 
basic interventions as a single-factor structure. The global 
measurement model showed good fit to the data, thus support-
ing the discriminant validity of the basic interventions factor: 
χ2 (df ) =773.497 (430), p,0.001, RMSEA (90% CI) =0.062 
(0.055–0.069), CFI =0.967, and TLI =0.962.
correlations between factors
As a previous step before testing the SEM, we offer evidence 
supporting the discriminant validity of all factors analyzed. 
Thus, we present the correlations between the latent factors that 
would be included within the structural model (Table 4). As 
can be observed, correlations between SASMAT-METHER 
factors and basic interventions were low (ie, 0.20–0.39), 
whereas correlations between SASMAT-METHER factors 
ranged from low to moderate (0.40–0.59).
Testing a model of patient satisfaction 
with MMT 
The results of the structural model tested in this study are 
presented in Figure 1. In this model, SASMAT-METHER 
factors were defined using an ESEM approach, and basic 
interventions were specified as a single-factor structure. 
The structural model hypothesized that patient satisfaction 
Table 3 sAsMAT-MeTher measurement models comparison
Model χ2 (df) p-value RMSEA
(90% CI)
CFI TLI Δχ2 (Δdf) p-value ΔRMSEA ΔCFI ΔTLI
Model 1 – ESEM 200.546 (88) ,0.001 0.078
(0.064–0.092)
0.983 0.973
Model 2 – three 
correlated factors cFA 
312.420 (116) ,0.001 0.090
(0.078–0.102)
0.970 0.964 115.675 (28) ,0.001 0.012 -0.013 -0.009
Model 3 – three 
uncorrelated factors cFA 
934.044 (119) ,0.001 0.181
(0.170–0.191)
0.874 0.856 135.274 (3) ,0.001 0.091 -0.096 -0.108
Model 4 – one factor 1,550.953 (119) ,0.001 0.239
(0.229–0.250)
0.778 0.747 282.187 (3) ,0.001 0.149 -0.192 -0.217
Notes: The table presents the taxonomy of nested measurement models. The selected model is highlighted in bold.
Abbreviations: sAsMAT-MeTher, scale to assess satisfaction with medications for addiction treatment – methadone for heroin addiction; eseM, exploratory structural 
equation model; CFA, confirmatory factor analysis; RMSEA, root mean square error of approximation; CI, confidence interval; CFI, comparative fit index; TLI, Tucker–Lewis 
index.
Table 4 subscale data and correlations between factors
Factor Mean (SD) % satisfied 1 2 3 4
sAsMAT-MeTher
1. Personal functioning and well-being 3.31 (0.80) 65.2 1
2. Anti-addictive effect on heroin 3.78 (0.86) 78.6 0.488 1
3. Anti-addictive effect on other substances 2.88 (0.94) 42.3 0.304 0.431 1
Vsss-MT
4. Basic interventions 3.58 (0.76) 77.1 0.299 0.286 0.265 1
Notes: % satisfied = patients with a score .3 in a particular subscale. All latent correlations were significant at p,0.001. 
Abbreviations: sAsMAT-MeTher, scale to assess satisfaction with medications for addiction treatment – methadone for heroin addiction; Vsss-MT, Verona service 
satisfaction scale for methadone-treated patients.




Patient satisfaction with methadone medication and treatment
with methadone as a medication was an antecedent of patient 
satisfaction with the basic interventions conducted at treat-
ment centers. The model exhibits a good fit to the data: χ2 
(df ) =773.497 (430), p,0.001, RMSEA (90% CI) =0.062 
(0.055–0.069), CFI =0.967, and TLI =0.962. As can be 
observed, patient satisfaction with the effects of methadone 
on their personal functioning and well-being, as well as 
methadone anti-addictive effect on non-opioid substances, 
significantly and positively predict patient satisfaction with 
the basic interventions conducted at their methadone treat-
ment centers (β=0.191 and β=0.152, respectively). All three 
SASMAT-METHER factors combined explain 13.4% of the 
basic interventions variance.
Discussion
In the present study, we tested a structural model of satisfac-
tion with MMT in a sample of heroin-dependent patients, 
who were non-responders to methadone treatment. This 
model assumed that patient satisfaction with methadone as 
a medication would influence patient satisfaction with the 
basic MMT interventions delivered by the staff. Our results 
partially support the hypothesized model. Specifically, 
patient satisfaction with their own personal functioning 
and well-being as well as with the anti-addictive effects of 
methadone on non-opioid substances of abuse positively, but 
weakly, predicts satisfaction with the interventions conducted 
at MMT centers, whereas satisfaction with the anti-addictive 
effects of methadone on heroin does not. These results are 
consistent with Trujols et al’s theoretical model, regarding 
the capability of heroin-dependent patients to discriminate 
between their experiences with methadone medication 
and their judgment of the clinical staff who delivers this 
medication.9
Shikiar and Rentz pointed out that patient satisfaction 
with medication could have an impact on satisfaction with 
other areas of patients’ treatment.8 In this study, two dimen-
sions of patient satisfaction with methadone, namely per-
sonal functioning and well-being and anti-addictive effects 
of methadone on non-opioid substances, predict patient 
experiences with the staff interventions received. These 
relations are relatively small but are of clinical importance. 
In fact, the moderate percentage of explained variance may 
be interpreted as a favorable result. Our initial concern was 
that satisfaction with methadone could have a strong impact 
on satisfaction with the interventions conducted by clinical 
staff. However, our results show that this relation is not 
strong, suggesting that patient relationships with clinical 
staff might probably be safeguarded even when medication 
is not effective.
In addition, we also expected that satisfaction with metha-
done regarding its anti-addictive effects on heroin would be 
the main predictor of patient experiences with MMT basic 
interventions. The assumption was based on the idea that 
the primary therapeutic effect of methadone administration 
is decreasing the use of heroin and reducing the severity of 
heroin addiction.2,3 However, the path between both variables 
was not statistically significant, suggesting that patients 
could be satisfied or dissatisfied with the staff interventions 
Figure 1 Structural model describing the influence of SASMAT-METHER factors on patient satisfaction with the basic interventions conducted at methadone treatment 
centers.
Notes: All coefficients are standardized. *p,0.05.
Abbreviation: sAsMAT-MeTher, scale to assess satisfaction with medications for addiction treatment – methadone for heroin addiction.





regardless of their satisfaction with the pharmacological 
effects of methadone on heroin. As the study began in 2007, 
a possible explanation is that patients knew that methadone 
was the only option for maintenance treatment regardless 
of whether they were satisfied with it or not (ie, the Spanish 
Ministry of Health first regulated prescription buprenorphine-
naloxone in 2010) and understood that physicians were unable 
to suggest a different medication. Another explanation may be 
related to the statistical analysis. In this study, the correlation 
matrix showed that satisfaction with opioid effects had a posi-
tive, statistically significant association with satisfaction with 
basic interventions. However, when we included this variable 
in the SEM, its relevance decreased. As its correlation with 
personal functioning and well-being had the greatest value, 
we speculate that some degree of collinearity between both 
variables could be responsible for this result. 
The present study also offers further evidence regard-
ing the measurement model of the SASMAT-METHER.15 
Specifically, results support the selection of a three-factor 
model based on ESEM. This model exhibited a satisfac-
tory fit to the data, with all three factors being correctly 
identified. It should be noted that the model with three 
correlated factors based on CFA also showed a satisfac-
tory fit to the data. In addition, we also provided evidence 
supporting the internal consistency of the SASMAT fac-
tors through optimal omega coefficient values. Our results 
strengthen the line of previous research developed with this 
instrument16,35 and support the SASMAT-METHER as valid 
instrument to assess patient satisfaction with methadone as 
a medication.
limitations and future research
First, the present investigation was cross-sectional in nature; 
therefore, longitudinal designs are warranted to confirm the 
theoretical relations tested in this study.8,9 Second, the data 
assessing basic treatment interventions were based upon a 
self-report instrument (ie, VSSS-MT), which may not be 
an accurate reflection of how professionals really behave. 
However, it was the perception of those behaviors that was 
of interest in studies about patient satisfaction with treatment. 
Third, the sampling method was accidental and limited to 
Spanish non-responders to MMT, and thus may not ensure 
representativeness of all opioid-dependent patients. However, 
such sampling method allowed us to only include partici-
pants who were in stabilized clinical condition at the time of 
assessment, which surely reduced the influence of potential 
substance intoxications or withdrawals on patients’ opinions. 
Still, future research is needed to replicate the findings of the 
present study by using other samples, such as responders to 
MMT who are following outpatient treatment and/or patients 
in MMT from different countries.
Conclusion
The present study represents the first attempt to define how 
heroin-dependent patient satisfaction with methadone as a 
medication influences satisfaction with the basic interven-
tions implemented at treatment centers. Specifically, our 
structural model suggests that those patients satisfied with 
the effects of methadone on their personal functioning and 
well-being, as well as with its anti-addictive effects on non-
opioid substances, would be inclined to be more satisfied 
with the basic interventions received at treatment centers. 
In the current study, we also extend the existing literature 
by providing further evidence supporting the measurement 
model of the SASMAT-METHER, highlighting its role as 
a remarkable evaluation tool to measure satisfaction with 
methadone as a medication.
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